In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $54.00. The company's shares closed last Wednesday at $49.86. According to TipRanks.com, Biasio is a 4-star analyst with an average return of 7.0% and a 61.3% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Coherus Biosciences, and Intuitive Surgical. Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $57.42, which is a 15.3% upside from current levels.
https://www.tipranks.com/news/blurbs/pfizer-pfe-gets-a-hold-rating-from-credit-suisse-3?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more Pfizer Charts.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more Pfizer Charts.